Suppr超能文献

酒精相关性肝病的流行病学。

Epidemiology of Alcohol-Associated Liver Disease.

机构信息

Division of Gastroenterology and Hepatology, Department of Medicine, Indiana University School of Medicine, 702 Rotary Circle, Indianapolis, IN 46202, USA; Key Laboratory of Carcinogenesis and Translational Research, Peking University Cancer Hospital, Beijing, China.

Division of Gastroenterology and Hepatology, Department of Medicine, Indiana University School of Medicine, 702 Rotary Circle, Indianapolis, IN 46202, USA.

出版信息

Clin Liver Dis. 2021 Aug;25(3):483-492. doi: 10.1016/j.cld.2021.03.009. Epub 2021 May 26.

Abstract

Alcohol-associated liver disease (ALD) is a consequence of excessive alcohol use. It comprises a spectrum of histopathologic changes ranging from simple steatosis, steatohepatitis, and cirrhosis to hepatocellular carcinoma. The public health impact of ALD is growing because of an increase in the prevalence and incidence of ALD in parallel with liver transplant and mortalities. There are multiple factors involved in the pathogenesis and progression of ALD. Reducing alcohol consumption is the cornerstone of ALD management. The efforts to reduce excessive alcohol use at the individual and population levels are urgently needed to prevent adverse outcomes from ALD.

摘要

酒精相关性肝病(ALD)是过量饮酒的后果。它包含一系列组织病理学变化,从单纯性脂肪变性、脂肪性肝炎和肝硬化到肝细胞癌不等。由于ALD 的患病率和发病率与肝移植和死亡率平行增加,ALD 的公共卫生影响正在增加。ALD 的发病机制和进展涉及多种因素。减少酒精摄入是 ALD 管理的基石。迫切需要在个人和人群层面上减少过量饮酒,以防止 ALD 的不良后果。

相似文献

1
Epidemiology of Alcohol-Associated Liver Disease.酒精相关性肝病的流行病学。
Clin Liver Dis. 2021 Aug;25(3):483-492. doi: 10.1016/j.cld.2021.03.009. Epub 2021 May 26.
3
Nonalcoholic fatty liver disease and hepatocellular carcinoma.非酒精性脂肪性肝病与肝细胞癌
Metabolism. 2016 Aug;65(8):1151-60. doi: 10.1016/j.metabol.2016.01.010. Epub 2016 Jan 23.
7
Alcohol-associated liver disease-Global epidemiology.酒精性肝病——全球流行病学
Hepatology. 2024 Dec 1;80(6):1307-1322. doi: 10.1097/HEP.0000000000000899. Epub 2024 Apr 19.

引用本文的文献

6
Advances in the management of alcohol-associated liver disease.酒精性肝病管理的进展
Gastroenterol Rep (Oxf). 2024 Nov 5;12:goae097. doi: 10.1093/gastro/goae097. eCollection 2024.
7
Mitochondrial quality control in alcohol-associated liver disease.酒精相关性肝病中的线粒体质量控制。
Hepatol Commun. 2024 Oct 24;8(11). doi: 10.1097/HC9.0000000000000534. eCollection 2024 Nov 1.
8
Diagnosis of Alcohol Use Disorder and Alcohol-Associated Liver Disease.酒精使用障碍和酒精相关肝病的诊断。
Clin Liver Dis. 2024 Nov;28(4):699-713. doi: 10.1016/j.cld.2024.06.009. Epub 2024 Aug 13.
9
Novel medications for problematic alcohol use.新型治疗酒精使用障碍的药物
J Clin Invest. 2024 Jun 3;134(11):e172889. doi: 10.1172/JCI172889.
10
Non-invasive tests for alcohol-associated liver disease.酒精性肝病的非侵入性检测
Hepatology. 2024 Dec 1;80(6):1390-1407. doi: 10.1097/HEP.0000000000000885. Epub 2024 Apr 12.

本文引用的文献

4
Non-alcoholic fatty liver disease.非酒精性脂肪性肝病。
Clin Med (Lond). 2020 Sep;20(5):509-512. doi: 10.7861/clinmed.2020-0696.
7
The Association Between Alcoholic Liver Disease and Alcohol Tax.酒精性肝病与酒税之间的关联。
Am Surg. 2021 Jan;87(1):92-96. doi: 10.1177/0003134820945223. Epub 2020 Aug 19.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验